SlideShare une entreprise Scribd logo
1  sur  89
Solid state analysis and
     degradation profile




DEPARTMENT OF QUALITY ASSURANCE

                                  1
INTRODUCTION
• The normal route of administration for most
  pharmaceutically active agents is through
  the use of solid dosage forms, and these
  units are ordinarily produced by the
  formulation and processing of powdered
  solids.

• The priority of regulatory bodies has always
  focused on concerns of safety and efficacy,
  which led to emphasis on aspects of
  chemical purity.
• This situation has changed drastically over
  the past decade, with an ever-increasing
  degree of attention being given to the
  physical   properties    of   the   solids   that
  compromise a dosage form.
• solid-state reactions can affect the stability of
  a drug entity, so physical aspects of a
  formulation can not be ignored.
• sufficient physical information is necessary for
  formulator to overcome problems.
• For a well-understood system, it is
  theoretically possible to design an automated
  or semi automated manufacturing scheme for
  which     the     processing    variables   are
  appropriately controlled and the possibility of
  batch failure is, hence, minimized.
• It is presently recognized that to avoid
  problems during drug development, the
  physical characterization of bulk drugs,
  excipients, and blends of them should become
  part of the normal process.
• Study of polymorphs and solvatomorphs is very
   important.
• The nature of the crystal structure adopted by a
  given compound upon crystallization exerts a
  profound effect on the solid-state properties of that
  system, and that these variations can translate into
  significant differences in properties is of
  pharmaceutical importance.
• It is now accepted that an evaluation of the
  polymorphism available to a drug substance must
  be thoroughly investigated early during the stages
  of development.
• The results of these studies must be included in
 the chemistry, manufacturing, and control section
 of a new drug application, and such information is
 required to demonstrate       control   over   the
 manufacturing process.

• Therefore a systematic approach to the physical
 characterization of pharmaceutical solids has
 been outlined and serves as a useful device for
 the classification of the many methods of physical
 characterization.
• Based on this system, physical
  properties are classified as being
  associated with

• The molecular level (those associated with
  individual molecules),
• The particulate level (those pertaining to
  individual solid particles),
• The bulk level (those associated with an
  assembly of particulate species).
• I. PROPERTIES ASSOCIATED WITH THE
  MOLECULAR LEVEL
• A. Ultraviolet/Visible Diffuse Reflectance Spectroscopy
• B. Vibrational Spectroscopy
• C. Nuclear Magnetic Resonance Spectrometry

• II. PROPERTIES ASSOCIATED WITH THE
  PARTICULATE LEVEL
• A. Microscopy
• B. X-Ray Diffraction
• C. Thermal Methods of Analysis

• III. PROPERTIES ASSOCIATED WITH THE
  BULK LEVEL
• A. Particle Size Distribution
• B. Micromeritics
• C. Powder Characterization.
PROPERTIES ASSOCIATED
 WITH THE MOLECULAR LEVEL
• A. Ultraviolet/Visible Diffuse
  Reflectance Spectroscopy
• B. Vibrational Spectroscopy
• C. Nuclear Magnetic Resonance
  Spectrometry
A. Ultraviolet/Visible Diffuse
        Reflectance Spectroscopy
• Most solids are too opaque to permit the conventional
  use    of    ultraviolet/visible (UV/VIS)   electronic
  spectroscopy.
• As a result, such work must be performed using diffuse
  reflection techniques.
• Ultraviolet/Visible Diffuse Reflectance Spectroscopy is
  applied to
• -- study the reaction pathways of various solid-state
  reactions.
• --The fields of colour measurement and colour matching,
  areas that can be of considerable importance when
  applied to the coloring agents used in formulations.
• It is very useful tool for the study of
  interactions   among various formulation
  components, and the technique has been
  successfully used in the characterization of
  many solid-state reactions.

• Investigations conducted under appropriately
  designed stress conditions have been useful in
  the study of drug-excipient interactions, drug
  degradation pathways, and alterations in
  bioavailability .
• EX: diffuse reflectance spectroscopy is used to
  study the adsorption of spiropyrans onto
  pharmaceutically relevant solids.
• The particular adsorbents studied were
  interesting in that the spectral characteristics of
  the binary system depended strongly on the
  amount of material bound.
• At low concentrations, the pyran sorbent
  exhibited its main absorption band around 550
  nm.
• As adsorption increased, the 550-nm band was
  still observed, but a much more intense
  absorption band at 470 nm became prominent.
• This secondary effect was attributed to the
  presence of pyran–pyran interactions, which
  became more important as the concentration
  of sorbent increased.
B. Vibrational Spectroscopy
• Mid-infrared electromagnetic radiation is 400–
  4000 cm−1 utilized for analysis based on
  fundamental vibrational modes of a chemical
  compound.
• Fourier-transform infrared spectroscopy (FTIR)
  is now the method of choice.
• Vibrational transitions also can be observed
  using Raman spectroscopy.
• Overtones and combination bands of vibrational
  modes are observed in the near-infrared region
  of the spectrum (4000–13,350 cm−1).
• This all techniques are utilized for the physical
  characterization of pharmaceutical solids.
• When the structural characteristics of a solid affects
  the pattern of vibrational motion for a given
  molecule, these alterations can be used as a
  means to study the solid-state chemistry of the
  system.
• FTIR spectra often are used to evaluate :
  --the type of polymorphism that exists in a drug
  substance and
   --can be very useful to study the water contained
  within hydrate species.
• Solid-state IR absorption spectra often are
  obtained on powdered solids through the
  combined use of FTIR and diffuse reflectance
  detection, and interpreted through conventional
  group frequency compilations.
• For example, glisentide has been obtained in a
  number of polymorphic and solvatomorphic
  forms, with the anhydrous forms I and II
  exhibiting large differences in infrared spectra.
• The IR spectra of forms I and II are shown in
  Figure 1.
FIGURE 1 Infrared absorption spectra of glisentide:
    upper trace, form I; lower trace, form II.
• It can be noted that two bands assigned to
  the urea carbonyl group are found at 1635
  and 1545 cm−1 in form I and at 1620 and
  1545 cm−1 in form II. In addition, the
  shoulder that is present in both forms is more
  intense in the spectrum of form II.
• The S O stretching band is observed at 1157
  cm−1 in the spectrum of form I, but for form II
  it shifts to 1165 cm−1.
• The aromatic carbonyl group at 1720 cm−1 is
  present in both spectra, but is broadened in
  the case of form II.
• Another    technique      of     vibrational
 spectroscopy that is ideally suited for
 characterization   of   solids   is    Raman
 spectroscopy. In this methodology, the
 sample is irradiated with monochromatic
 laser radiation, and the inelastic scattering
 of the source energy is used to obtain a
 vibrational spectrum of the analyte.
• The Raman spectrum generally resembles the
  spectrum obtained using the FTIR method.
• Differences in peak intensity are often observed.
  (Owing to the fundamentally different selection
  rules associated with the phenomenon)
• In general, symmetric vibrations and non- polar
  groups yield the most intense Raman scattering
  bands. whereas antisymmetric vibrations and
  polar groups yield the most intense infrared
  absorption bands.
EX.
• Raman spectroscopy was used to study
  the effect of pressure and temperature on
  the phase composition of fluoranil crystals.
• Figure 2 shows the Raman spectra
  obtained at a series of increasing
  pressures, where the changes in band
  frequency indicate the existence of
  pressure-induced phase transitions.
FIGURE 2 Raman spectra obtained at 300 K for crystalline
           fluoranil at pressures of (a) 1 atm,
      (b) 0.5 GPa, (c) 1.4 GPa, and (d) 2.4 GPa.
• It was deduced from sharp discontinuities
 in the Raman spectra that a phase
 transition took place at a temperature of
 around 180 K if the pressure was 1 atm.

• This transition shifted to 300 K if the
 pressure was increased to 0.8 GPa.
• Near-IR spectra consist of overtone transitions of
  fundamental vibrational modes and are not,
  therefore, generally useful for identity purposes
  without the use of multicomponent analysis.
• But it is utilized in solid state analysis of the
  compounds that contain unique hydrogen atoms.
• For example, studies of water in solids can be
  easily     performed      through      systematic
  characterization of the characteristic OH band,
  usually observed around 5170 cm−1.
• The determination of hydrate species in an
  anhydrous matrix can be performed easily using
  near-IR analysis.
• The near-IR technique has been used very
  successfully for moisture determination,
  whole tablet assay, and blending validation.
• It is possible to use the overtone and
  combination bands of water to develop near-
  IR methods that have accuracy equivalent to
  that obtained using Karl–Fischer titration.
C. Nuclear Magnetic Resonance
          Spectrometry
• The ultimate molecular level characterization of
  a pharmaceutical material is performed on the
  level of individual chemical environments of
  each   atom     in   the    compound,   and   this
  information     is   best   obtained    by    NMR
  spectroscopy.
• Advances in instrumentation and computer
  pulse sequences currently allow these studies to
• Solid-state NMR spectra is used to deduce
  nature of polymorphic variations,
  especially when polymorphism is
  conformational in nature.
 e.g. during development of Fosinopril
  sodium, a crystal structure was solved for
  most stable phase, but no such structure
  could be obtained for its metastable
  phase.
• NMR data suggest that additional
  conformational between the two
  polymorphs were associated with cis-trans
  isomerization along the peptide bond,
  which intern results in the presence of non
  equivalent molecules existing in the unit
  cell.
Why solid NMR spectrum is so different
          from liquid NMR?
• There are 3 major factors:
  1) dipolar broadening :
 The presence of a group of spins around a
  given spin may result in a number of
  interactions. The most important interaction
  between the spin and its surrounding spins is
  the dipolar interaction. It could be
  homonuclear or heteronuclear dipolar
  coupling. It is the dominant broadening factor
  in organic solids.
For the case of two spins, I and S , the
 approximate dipolar Hamiltonian can be
 written as:

 Hd = ½ ϒHϒCh2 (1-3cos2θ)(3IzSz-I×S)
             rHC

in liquid, all possible values of θ exist due to
 reorientational motion. The average value of
 cos2 θ is 1/3, 1[1] and the dipolar coupling
 averages to zero. In a crystal powder or
 amorphous solid, all orientations occur, cos2
 θ does not average to zero, there is a non
• -zero dipolar coupling, produce a broad line.
  This broadening may be of the order of 20
  kHz.

 2) Chemical Shift Anisotropy (CSA)

• This broadening factor arises from
  asymmetry     in    the     electron    density
  surrounding a given nucleus. In liquids an
  average chemical shift is observed due to
  averaging over all orientations on a timescale
  short in comparison with the NMR
  measurement time.
• In solid, a complex line shape result from a
  sum of all possible chemical shifts.

• The chemical shift anisotropy is again related
  to the term (3cos2θ-1). This term could be zero
  when the angle q is equal to 54044’. It is called
  magic angle.

• In practical circumstances, high resolution solid
  state NMR spectra can be obtained using a
  combination of dipolar decoupling and magic
  angle spinning (MAS).
• The dipolar decoupling is similar to that
  observed in liquid NMR. When acquiring a
  13C spectrum, proton decoupling is needed
  to decouple the proton attached to the
  carbon, since all other protons dipolar
  coupling are averaged by molecule self
  orientation.
• In the solid ,high power decoupling is
  necessary because of abundance of NMR
  active nuclei nearby, and could not average
  the interaction to zero.
• This is one of the reasons to use MgO to
  dilute the organic solids sample to avoid
  homonuclear dipolar coupling. The effect
  of , MAS is to remove chemical shift
  anisotropy and dipolar coupling . However
  , in order to suppress dipolar couplings,
  the spinning speed should fast than the
  strength of coupling in Hz.
3) Spin-spin Relaxation and Spin
           Lattice Relaxation
• The solids ,spin – spin relaxation time T2 is
  very short due to restricted motion. Under
  ideal conditions, the residual line width
  following decoupling and MAS will be
  determined by the magnitude of T2. the
  inherent line width is therefore much broad
  than that found in liquid state NMR, in tens
  of Hz is normal .
• In solid, spin lattice relaxation is very inefficient
  and T1 is very long, in tens of seconds, due to
  the restricted motion. A long pulse delay is
  required to re-establish thermal equilibrium.
  This could be over come by using cross
  polarization technique.
• To observe rare spins 13Cin solids, there are
  no significant homonuclear couplings since they
  are far away from each other in the sample .on
  the other hand, the hetronuclear coupling
  between the rare spins(13C) and abundant
  spins(1H) are dominant.
• By using abundant spins to enhance the
 rare   spin   signals    under   appropriate
 condition is known as polarization transfer
 or cross-polarization.

• In liquids, the polarization transfer was
 originally achieved by experiment INEPT. In
 solids , the polarization transfer could be
 achieved by spin lock under Hartmann-
 Hahn condition.
Properties Associated With Particulate
Level:-
• Particulate properties are defined as those
   material characteristics that effectively can
   be determined by the analysis of a
   relatively small ensemble of particles.
I. Microscopy
i. X-Ray diffraction
ii. Thermal mode of analysis
i. Microscopy :-
Estimation of the particle size distribution in a
 powdered sample is obtained by microscopy
 method . The relative crystallinity of the
 material readily determined by this method .
The micromeritic and bulk powder property of
 the material is highly influenced by the
 evaluation of the morphology of
 pharmaceutical solids.
There are mainly two types of microscopy ;
    1) Optical microscopy
    2) Electron microscopy
Magnificent limit for Optical Microscopy for
 routine work is 600x,whereas electron
 microscopy can be performed at
 extraordinarily high magnification levels up to
 90,000X on most units and the images
 contain three-dimensional information.
B)X-Ray Diffraction
• The fundamental structural information on
  crystalline substances obtained by the
  technique of X-ray diffraction.
• Bragg explained the diffraction of x-rays by
  crystals using a model where the atoms of a
  crystal are regularly arranged in space and
  where they can be regarded as lying in
  parallel sheets separated by a definite and
  defined distance.
• Application
1) Determination of crystal structures
2) Evaluation of polymorphism
3) Solvate Structures
4) Evaluation of degrees of crystallinity
(c) Thermal Methods of Analysis

• This analytical method is used to
  characterize        compound        purity,
  polymorphism, salvation, degradation
  and excipient compatibility
• By the thermal analytical method
  endothermic processes (melting, boiling,
  sublimation, vaporization, desolvation,
  solid-solid phase transitions and chemical
  degradation) as well as exothermic
• Processes (crystallization and oxidative
  decomposition) can be evaluated.
• These are the techniques used to
  determine a property of the analyte as a
  function of      an   externally   applied
  temperature. The property of analyte is
  evaluated on a continuous basis as a
  function of temperature.
• The major advantage of this method is it is
  extremely useful during the conduct of
  preformulation studies, because carefully
• planned studies can be used to indicate
  the existence of possible drug-excipient
  interactions in a prototype formulation.
Differential Thermal Analysis(DTA)

• This technique of thermal analysis is
  having an excellent qualitative advantage
  that is useful to deduce the temperature
  ranges associated with a variety of thermal
  events, as well as to assign the
  endothermic or exothermic nature of these
  reactions.
• DTA represents an improvement to the
  melting point determination in that the
• Different temperature between the sample
  and a reference is monitored as a function
  of temperature.
• However, differences in temperature
  between the sample and reference are
  manifested when changes occur that
  require a finite heat of reaction.
• When the heat capacities of the two that is
  sample and reference roughly equivalent
  the temperature of the sample and the
  reference will be same due to the no
  theremal transitions take place
• If for the transition is positive (endothermic
  reaction) the temperature of the sample
  will lag behind that of the reference
  (because more heat will be absorbed by
  the sample than by the reference) and this
  event will be recorded in the thermogram
  as a negative-going peak.
• If the H is negative (exothermic reaction) ,
  the temperature of the sample will exceed
  that of the reference (because the sample
  itself will be a source of additional heat )
  and the event will be recorded in
  thermogram as a positive going peak.
Differential scanning Calorimetry (DSC)

• An improvement to DTA analysis is
  Differential scanning Calorimeter (DSC)
  and has become one of the most widely
  used methods of thermal analysis.
• DSC method involves the measurement of
  the heat flow required to maintain the
  equality in temperature between the
  sample and the reference when they kept
  at same temperature.
• By placing separate heating elements in
  the sample and the reference cell, the
  equality can be achieved. The rate of
  heating by these elements is controlled
  and measured.
• This method of measurement is termed
  power-compensation DSC, and it yields
  positive-going peaks for endothermic
  transitions and negative going peaks for
  exothermic transitions.
Lactos monohydrate (Fig:b)
• The thermal transitions can be seen in the DSC
  curves. The curve for anhydrous lactose (fig. a)
  shows an endothermic melting peak at about 235 C
• The lactose monohydrate (fig. b) dehydrates around
  150 C ; the resulting anthydrous lactose melts at
  about 220 C
• The small exothermic peak at 180 C can be
  attributed to the recystallisation of some of the
  anhydrous lactose into mixed crystal the thermal
  effects after the melting peak of lactose are the
  result of melting of the mixed crystal and of
  decomposition of the liquefied lactose.
Thermogravimetry (TG)
• The thermally induced weight loss of a
  material is measured as a function of the
  applied temperature” is the main principle
  behind the thermogravimety (TG) of
  thermoanalytical technique.
• The quantitative determination of the total
  volatile contents of a solid is the major use
  of TG analysis. The magnitude of each
  step can be separately evaluated, when a
  solid decompose by means of several
  discrete, sequential reactions.
• It is most commonly used to study desolvation
 Processes      and     compound        decomposition
 because this method is restricted to studies that
 involve either a mass gain or loss (usually loss).
• The stability of similar compounds can be
 compare      by   TG        analysis   of   compound
 decomposition. The higher the decomposition
 temperature of given compound, the more
 negative is the G vaiue and therefore the
 greater is the stability.
For E.g Degradation pattern of
         CuSO4. 5H2O
• CuSO4. 5H2O -- CuSO4. H2O (90 to150
  C)
• CuSO4. H2O --- CuSO4 (200 to 274 C)
• CuSO4 ------CuS +SO2 ½ O2 (700 to 900
  C)
• 2CuO -- Cu2O + ½ O2 (1000 to 1100 C)
PROPERTIES ASSOCIATE WITH BULK
                      LEVEL
• Bulk properties are those characteristics of
  a solid that can be measured only for large
  ensemble particles.
• In latter stages of drug development the
  physical characteristic compatibility of drug
  with other formulation ingredients is in
  important.
• Excipients show physical effects like
  enhancing powder compaction promoting
  dissolution, modifying drug release rate and
  improve powder flowabillty
• This evaluation requires program for
  physical characterization of excipients
  especially w.r.t properties related to their
  use and functionaliy.
Particle size Distribution

• Particle size distribution of API and
  excipients exerts profound effect on mixing
  and possible segregation and hence affect
  bioavailability and powder flowability.
• In absence of electrostatic effects, it is
  easy to produce homogenously mixed
  powders if the individual components to be
  mixed are of equivalent particle size.
• All pharmaceutical dosage forms must be
  uniform and good content uniformity is
  possible only when particle size of API is
  carefully controlled.
• Variety of methods are available for this
  determination
• Optical microscopy (usually combined with
  image analysis )
• Sieve analysis
• Laser light scattering of suspended
  particles
• Electrical zone sensing
• When proper sampling techniques are
  use, most absolute method used is
  Microscopy which becomes most efficient
  when combined with some form of image
  analysis
• In    automated    method,      microscope
  parameters are adjusted to optimize
  contrast    between      background    and
  particles to be sized video image of
  powder is transmitted to a computer
  system which counts the number of pixels
  that make up a particle.
• The size of each pixel is easily converted
  to um and data are analyzed as desired-
  Average particle size, Full weight
  distribution or Shape information, etc.
Advantages of optical Microscopy :-
• Provides direct and absolute information
  on the particles under study.
• Sieve analysis is simplest and widely used
  method.
• Here the particles are allowed to distribute
  among a series of sieves (typically wire
  mesh) and the amount of material retained
  on each sieve is determined.
• FINES– Smaller particles that passes
  through sieve
• COARSE particles– Larger particles that
  remains on sieve
• MEDIUM fractions – when multiple sieves
  are used the intermediate sized particles
  that passes through one or more sieve
  but retained on subsequent sieve.
• Facilitation   method    like     vibration
  ultrasound or air suspension are used to
  assist the passage of particles through
  various
• A proper size detemination required use of
  5-6 sieves whose sizes are selected to
  obtain approx. equal amount of powder on
  each sieves and past the smallest sieve.
• % material retained on each sieve.
  Cumulative% of sample retained and %
  sample passing each sieve are obtained.
• Electrical zone sensing (is based on the
  coulter principle ) use measurement of
  electrical pulses caused by passage of
  particles through a sensing zone to get
  size information.
Micromeritics :-
• For powders, micromeritics is related to
  the nature of the surfaces that make up
  the solid.
• Of all the properties that could be
  measured
Surface area
Porosity and
Density are most revelant pharmaceutical
  parameters.
• SURFACE AREA – Provides information on
  the available void spaces on surface of a
  powdered solid and Dissolution rate is also
  partially determined.
• Most reproducible measurements of the
  surface area of solids are obtained by
  adsorbing a monolayer of inert gas onto the
  solid surface at reduced temperature and
  subsequently desorbing this gas at room
  temperature. The sorption isotherms are them
  interpreted using equations of BET method.
• Unit- square meters of surface per gram of
  material
• POROSITY – mercury intrusion porosimetry
 is the most widely used method to detemine
 pore size distribution of a porous Materials
 and void size of tablets and compacts. This
 method is based on capillary rise
 phenomena where excess pressure is
 required to force a nonwetting liquid into a
 narrow volume.
• Mercury with contact angle of approx. 140
  with glass is commonly used as an intrusion
  fluid it is forced into the pores of a sample
  using as an intrusion fluid. It is forced into the
  pores of a sample using an externally applied
  pressure where the smallest pores require
  highest pressure to effect filling.
• DENSITY- is ratio of mass to volume 3 types
  of density which differ in their determination
  of volume occupied by the powder are
  normally differentiated.
• Bulk density is obtained by measuring the
  volume of known mass of powder sample
  (that has been passed through a mesh
  screen ) into a suitable volume measuring
  apparatus like graduated cylinder. The
  bulk density is then obtained by dividing
  the mass of solid by the unsettled
  apparent volume.
• Tapped density is obtained by measuring
  the volume of solid after subjecting the
  system to a number of controlled shocks.
  Into a smaller volume. So tapped density
  is always higher than bulk density.
• True density is an intrinsic property of the
  analyte and is determined by composition
  of the unit cell. It is average mass per unit
  volume, exclusive of all voids that are not
  a fundamental part of the molecular
  packing arrangement.
• It is measured by Helium pycnometry,
  where the volume occupied by a know
  mass of powder             is determined by
  measuring the volume of gas disolaced by
  the powder.
Powder Characterization
• Flowability of powder is important
  parameter for formulators because the
  materials need to be moved from place to
  place.
• E.g. For tablets compressed at high speed
  the efficiency of machine is suitable only it
  powder feed delievered at high rate.
• Many pharmaceutical compounds with
  cohesive nature have undersirable flow
  properties.
• One of the alms of granulation is to reduce
  this cohesiveness to produce uniform
  blend      with more suitable physical
  properties.
• Powder flowability is evaluated using
• Angle of repose (angle formed when a
  cone of powder is poured onto a flat
  surface)
• Angle of spatula ( angle formed when
  material is raised on a flat surface out of a
  bulk pile)
• Compressibility      (obtained       from
  measurement of the bulk and tapped
  densities)
• Cohesion (attractive forces that exist on
  particle surfaces )
IMPURITIES AND DEGRADATION
             PROFILE
• What is Impurities ???

  – Impurities in pharmaceuticals are the unwanted
    chemicals that remain with API or develop during
    formulation or upon aging.

  – The presence of these unwanted chemicals even
    in small amounts may influence the efficiency
    and safety of the products.


                                                 73
Source of Impurities in Formulation




      Impurities associated with                Impurities created during formulation &
                 API                             aging or related to formulation forms




 Organic     Inorganic     Residual   Process      Environmental    Dosage Form      Functional
Impurities   Impuritie     Solvents   Related         Related       factor related     Group
                 s                                                                    related
                                                                                          74
Impurities Associated with API
                        Organic Impurities
                  (Process / Degradation Product)




  Starting       By products          Reagents,         Degradation
  Material                         Ligands, Catalyst     Product
                e.g.
e.g. 4-         Diacetylated       Mandelic acid in    e.g. Hydroxy
aminophenol     Paracetamol as     Esomeprazole        acid in
in              by product in      Mag.                Simvastatin,
Paracetamol,    manufacturing                          Impurity D in
Loratadine in   of Paracetamol                         Amlodipine
Desloratadine                                          Besylate
                                                                       75
DEGRADATION
• Solid state drug degradation occurs in a
  solution phase (in solvent layers
  associated with the solid phase ) source of
  solvent for such decomposition reaction
  may be :-
• A) A melt from the drug it self or an
  ingredient in the formulation with low
  melting point
• B) Residual moisture or solvent from wet
  granulation.
• C) Moisture adsorbed onto excipients such
  as starch, lactose, or microcrystalline
  cellulose.
• D) Adsorbed atmospheric moisture or
• E) Solvate or hydrate that losses its
  “bound” Solvent with time or temperature
  fluctuation.
Chemical decomposition of drugs in
solid state can be divided into 4
categories :-
(1) solvolysis /Hydrolysis :-
• It is most important reaction for solid state
  drug degrade on occuring mainly in
  compounds containing acy group
  involving decomposition of drug by
  reaction with solvent like Hydrolysis (with
  water as solvent) or other like
  decarboxylation, etc.
• Solvent acts as nucleophile attacking the
  electropositive center in drug molecules.
  E.g. NSAIDs, Barbiturates Vitamins, etc.
Protection against Hydrolysis
• Hydrolysis occurs in presence of moisture
  H+ or OH so protection steps from this
  reaction mainly involves their elimination
  from the drug system like-
• (a) Buffer :- it stabilizes the drug. Ph of
  solution is adjusted to give maximum drug
  stability and therapeutic activity.
• (b) Complexation :- Hydrolysis of
  Benzocaine in aq solution is inhibited by
  addition of caffeine which forms a complex
  with it
• (c ) suppression of solubility :- as drug
  solubility decreases. The conc of drug in
  solution phase also decreases so rate of
  hydrolysis is reduced.
• (d) Removal of water :- as water is
  responsible for hydrolysis its contacts
  with the drug is avoided in the preparation
  by
• Storing drug in dry form E.g. streptomycin
  dry powder injection.
• Using water immiscible vehicle for drug
  dispersion E.g. Aspirin in silicone fluid.
Oxidation
• It involves interaction of a chemical with
  oxygen mostly in a solvent although there
  are examples where oxygen may be able
  to oxidize drug in absence of a solvent.
• Oxidation means removal of electrons,
  electropositive atom or radical or addition
  of oxygen or removal of hydrogen
• 2 main types are :-
• Proceed slowly under influence of
  atmospherice oxygen
• Reversible loss of electrons without
  addition of Oxygen E.g.           Adrenaline
  Riboflavin
• In Pharmaceutical dosage forms, oxidation
  is usually AUTOOXIDATION (mediated by
  reaction with atmospheric oxygen under
  ambient condition ) E.g. Autooxidation of
  unsaturated fatty acids in fats and oils.
• E.g. Promethazine, Vitamin A Riboflavin
  Morphine, etc.
• System can be protected against oxidation
  by following ways :-
• (a) Antioxidants : - they or prevent the
  oxidation process. E.g. Tocopehrol,
  Butylated Hydroxyl Anisole (BHA) ,
  Butylated Hydroxyl Toluene (BHT), propyl
  gallate, etc,
• (b) Adjustment of Ph :- Potential (E) is
  influenced by PH of system . Decrease in
  Ph caused rise in E and hence increases
  resistance to oxidation.
• (c ) Micellar Solubilization :- Surfactans
  such as polysorbate enhances the rate of
  oxidation ascorbic acid at low conc but
  protects above its critical micelle conc
  (CMC) by entrapping the drug in spherical
  micelle.
Photolysis
• Photolysis of drugs like phenothiazine and
  vitamin A need Presence of solvent but
  sometimes       such      solvent-dependant
  reaction may not be needed.
• Light may cause substantial degradation
  of drug molecule by absorbing energy of
  particular wavelenght.
• Photochemical reaction – Molecules
  absorbing light takes part in photolysis and
  photosensitization –absorbing molecules
  don’t participate in photolysis.
• Photons of shorter wavelength have more
  energy so uv visible light can cause
  phctolysis.
• E.g.     Photodegradation      of    sodium
  Nitroprusside in aq solution
• Photo toxicity caused by drug is common
  Problem the Primary reaction for initiating
  this toxicity is generation of singlent-state
  excited oxygen.
• Prevention-store in dark or enclose it in an
  opaque wrapper or in light resistance
  containers which donot transmit more than
  15 % of incident radiation between 290-
Pyrolysis
• It is thermally induced bond rupture
  occuring in absence of solvent. It is
  normally not an important mechanism
  except when the drug is exposed in
  processing to a very high temp.
• E.g. P-aminosalicylic acid degradation at
  70-80 c range in the absence of molsture
  show a significant pyrolysis.
REFERENCES
• 1) Ahuj Satinder, scypinki stephen.
  Handbook of modem Pharmaceutical
  analysis 3rd ed. Academic press
• 2) Zornoza A, de No. C., Goni M.M.
  Martinez Oharriz M.C., and Velaz I lnt J.
  pharm. 186. 199. 1999.
• 3)
  http:/www.emory.edu/NMR/Hall/solid/index
  .htm
• 4) http:/www.bionmr-
  c1.unl.edu/921/Lectures/chapter11-solid-

Contenu connexe

Tendances

Detectors used in gas chromatography
Detectors used in gas chromatographyDetectors used in gas chromatography
Detectors used in gas chromatographyVrushali Tambe
 
Diffusion parameters liki
Diffusion parameters likiDiffusion parameters liki
Diffusion parameters likilikuradhe
 
Quantum numbers and its roles in nmr
Quantum numbers and its roles in nmrQuantum numbers and its roles in nmr
Quantum numbers and its roles in nmrAtul Adhikari
 
Types of crystals & Application of x ray
 Types of crystals & Application of x ray Types of crystals & Application of x ray
Types of crystals & Application of x raykajal pradhan
 
IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...
IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...
IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...Dr. UMESH KUMAR SHARMA
 
High performance thin layer chromatography
High performance thin layer chromatographyHigh performance thin layer chromatography
High performance thin layer chromatographySravani Ganti
 
FACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITYFACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITYaishuanju
 
FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]
FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]	FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]
FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR] Sagar Savale
 
Bioanalysis of drugs from biological samples
Bioanalysis of drugs from biological samplesBioanalysis of drugs from biological samples
Bioanalysis of drugs from biological samplesYachita Rajwadwala
 
UV Visible Spectroscopy
UV Visible SpectroscopyUV Visible Spectroscopy
UV Visible SpectroscopySimranDhiman12
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)HARSHALA DHENDE
 
UV visible spectroscopy principles and instrumentation
UV visible spectroscopy principles and instrumentationUV visible spectroscopy principles and instrumentation
UV visible spectroscopy principles and instrumentationSajjad Ullah
 
Ionizaion Techniques - Mass Spectroscopy
Ionizaion Techniques - Mass SpectroscopyIonizaion Techniques - Mass Spectroscopy
Ionizaion Techniques - Mass SpectroscopySuraj Choudhary
 
NMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja DonthulaNMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja Donthulahimaja donthula
 
salt selection in pharmaceutical product development
salt selection in pharmaceutical product developmentsalt selection in pharmaceutical product development
salt selection in pharmaceutical product developmentdilip kumar tampula
 
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsControlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsSuraj Choudhary
 

Tendances (20)

Detectors used in gas chromatography
Detectors used in gas chromatographyDetectors used in gas chromatography
Detectors used in gas chromatography
 
Diffusion parameters liki
Diffusion parameters likiDiffusion parameters liki
Diffusion parameters liki
 
Gas Chromatography
Gas ChromatographyGas Chromatography
Gas Chromatography
 
FLAME EMISSION SPECTROSCOPY
FLAME EMISSION SPECTROSCOPY FLAME EMISSION SPECTROSCOPY
FLAME EMISSION SPECTROSCOPY
 
Quantum numbers and its roles in nmr
Quantum numbers and its roles in nmrQuantum numbers and its roles in nmr
Quantum numbers and its roles in nmr
 
Types of crystals & Application of x ray
 Types of crystals & Application of x ray Types of crystals & Application of x ray
Types of crystals & Application of x ray
 
IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...
IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...
IR - Spectroscopy, theory, modes of vibration and sample handling. by Dr. Ume...
 
High performance thin layer chromatography
High performance thin layer chromatographyHigh performance thin layer chromatography
High performance thin layer chromatography
 
FACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITYFACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITY
 
Solid dispersion
Solid dispersionSolid dispersion
Solid dispersion
 
Dissolution and solubility
Dissolution and solubilityDissolution and solubility
Dissolution and solubility
 
FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]
FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]	FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]
FOURIER -TRANSFORM INFRARED SPECTROMETER [FTIR]
 
Bioanalysis of drugs from biological samples
Bioanalysis of drugs from biological samplesBioanalysis of drugs from biological samples
Bioanalysis of drugs from biological samples
 
UV Visible Spectroscopy
UV Visible SpectroscopyUV Visible Spectroscopy
UV Visible Spectroscopy
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)
 
UV visible spectroscopy principles and instrumentation
UV visible spectroscopy principles and instrumentationUV visible spectroscopy principles and instrumentation
UV visible spectroscopy principles and instrumentation
 
Ionizaion Techniques - Mass Spectroscopy
Ionizaion Techniques - Mass SpectroscopyIonizaion Techniques - Mass Spectroscopy
Ionizaion Techniques - Mass Spectroscopy
 
NMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja DonthulaNMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja Donthula
 
salt selection in pharmaceutical product development
salt selection in pharmaceutical product developmentsalt selection in pharmaceutical product development
salt selection in pharmaceutical product development
 
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsControlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and Applications
 

En vedette

Pharmaceutical Solid Form
Pharmaceutical Solid FormPharmaceutical Solid Form
Pharmaceutical Solid FormSimon Curtis
 
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APIAlmac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APISusan1Beattie
 
Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Linda_Mccausland
 
Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?Covello Luca
 
Solubility of poorly soluble drugs by using solid ppt
Solubility of poorly soluble drugs by using solid pptSolubility of poorly soluble drugs by using solid ppt
Solubility of poorly soluble drugs by using solid pptjagadeesh kumar
 
Solid state chemistry
Solid state chemistrySolid state chemistry
Solid state chemistryKumar
 
Rapidd™
Rapidd™Rapidd™
Rapidd™ejmckee
 
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Susan1Beattie
 
Almac solid state presentation 2013
Almac solid state presentation 2013Almac solid state presentation 2013
Almac solid state presentation 2013Susan1Beattie
 
Dr.V.chandrasekharan
Dr.V.chandrasekharanDr.V.chandrasekharan
Dr.V.chandrasekharanDipak Shetty
 
Crystals And IP April 2011
Crystals And IP April 2011Crystals And IP April 2011
Crystals And IP April 2011Linda_Mccausland
 
Solid State Capabilities
Solid State CapabilitiesSolid State Capabilities
Solid State Capabilitiesejmckee
 
Hejal parekh presentation
Hejal parekh presentationHejal parekh presentation
Hejal parekh presentationHejal Parekh
 
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)Mark_Sullivan
 
X-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsX-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsLinda_Mccausland
 
Polymorph Quantitation
Polymorph QuantitationPolymorph Quantitation
Polymorph Quantitationreychemist
 

En vedette (20)

Pharmaceutical Solid Form
Pharmaceutical Solid FormPharmaceutical Solid Form
Pharmaceutical Solid Form
 
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APIAlmac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
 
Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011
 
Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?Polymorphism: opportunity or problem?
Polymorphism: opportunity or problem?
 
Solubility of poorly soluble drugs by using solid ppt
Solubility of poorly soluble drugs by using solid pptSolubility of poorly soluble drugs by using solid ppt
Solubility of poorly soluble drugs by using solid ppt
 
Lecture 8: Phase Diagrams
Lecture 8: Phase DiagramsLecture 8: Phase Diagrams
Lecture 8: Phase Diagrams
 
Solid state chemistry
Solid state chemistrySolid state chemistry
Solid state chemistry
 
Rapidd™
Rapidd™Rapidd™
Rapidd™
 
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
 
Almac solid state presentation 2013
Almac solid state presentation 2013Almac solid state presentation 2013
Almac solid state presentation 2013
 
Dr.V.chandrasekharan
Dr.V.chandrasekharanDr.V.chandrasekharan
Dr.V.chandrasekharan
 
Crystals And IP April 2011
Crystals And IP April 2011Crystals And IP April 2011
Crystals And IP April 2011
 
Solid State Capabilities
Solid State CapabilitiesSolid State Capabilities
Solid State Capabilities
 
Hejal parekh presentation
Hejal parekh presentationHejal parekh presentation
Hejal parekh presentation
 
Phase Transformation.
Phase Transformation.Phase Transformation.
Phase Transformation.
 
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
 
X-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsX-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid forms
 
Polymorph Quantitation
Polymorph QuantitationPolymorph Quantitation
Polymorph Quantitation
 
Chapter 3
Chapter 3Chapter 3
Chapter 3
 
Phase transitions
Phase transitionsPhase transitions
Phase transitions
 

Similaire à 4016 solid state analysis

Characterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspectsCharacterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspectsvivek vyas
 
Spectrophotometry Shrraddha suman.pptx
Spectrophotometry Shrraddha suman.pptxSpectrophotometry Shrraddha suman.pptx
Spectrophotometry Shrraddha suman.pptxShrraddha
 
Spectrophotometer instrumentation
Spectrophotometer instrumentationSpectrophotometer instrumentation
Spectrophotometer instrumentationSmitha K R
 
Fluorimoetric and manometric methods of enzyme assay
Fluorimoetric and manometric methods of enzyme assayFluorimoetric and manometric methods of enzyme assay
Fluorimoetric and manometric methods of enzyme assayGokulArora
 
Flash and chiral chromatography
Flash and chiral chromatographyFlash and chiral chromatography
Flash and chiral chromatographyceutics1315
 
Techniques for measuring receptor binding – Its uses.pptx
Techniques for measuring receptor binding – Its uses.pptxTechniques for measuring receptor binding – Its uses.pptx
Techniques for measuring receptor binding – Its uses.pptxKarthikaRaveendran1
 
Analytical techniques in pharmaceutical
Analytical techniques in pharmaceuticalAnalytical techniques in pharmaceutical
Analytical techniques in pharmaceuticalZafar Mahmood
 
FT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharm
FT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharmFT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharm
FT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharmAnubhav Singh
 
Nephelometry and Turbidimetry
Nephelometry and TurbidimetryNephelometry and Turbidimetry
Nephelometry and Turbidimetrykumar ganesh
 
Advanced chromatographic techniques application Aquatic environmental studies...
Advanced chromatographic techniques application Aquatic environmental studies...Advanced chromatographic techniques application Aquatic environmental studies...
Advanced chromatographic techniques application Aquatic environmental studies...B. BHASKAR
 
INTRODUCTION TO SPECTROCOPY
INTRODUCTION TO SPECTROCOPYINTRODUCTION TO SPECTROCOPY
INTRODUCTION TO SPECTROCOPYTehseen Khalid
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Patel Parth
 

Similaire à 4016 solid state analysis (20)

Characterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspectsCharacterization of nanoparticles & its regulatory aspects
Characterization of nanoparticles & its regulatory aspects
 
Spectrophotometry Shrraddha suman.pptx
Spectrophotometry Shrraddha suman.pptxSpectrophotometry Shrraddha suman.pptx
Spectrophotometry Shrraddha suman.pptx
 
Application FTIR in medicine and dentistry
Application FTIR in medicine and dentistryApplication FTIR in medicine and dentistry
Application FTIR in medicine and dentistry
 
Liposomes
LiposomesLiposomes
Liposomes
 
Spectrophotometer instrumentation
Spectrophotometer instrumentationSpectrophotometer instrumentation
Spectrophotometer instrumentation
 
Fluorimoetric and manometric methods of enzyme assay
Fluorimoetric and manometric methods of enzyme assayFluorimoetric and manometric methods of enzyme assay
Fluorimoetric and manometric methods of enzyme assay
 
VOLUMETRIC ANALYSIS .pdf
VOLUMETRIC ANALYSIS .pdfVOLUMETRIC ANALYSIS .pdf
VOLUMETRIC ANALYSIS .pdf
 
HERBAL COSMETIC
HERBAL COSMETICHERBAL COSMETIC
HERBAL COSMETIC
 
Hplc (1)
Hplc (1)Hplc (1)
Hplc (1)
 
Flash and chiral chromatography
Flash and chiral chromatographyFlash and chiral chromatography
Flash and chiral chromatography
 
Flash and chiral chromatography
Flash and chiral chromatographyFlash and chiral chromatography
Flash and chiral chromatography
 
Techniques for measuring receptor binding – Its uses.pptx
Techniques for measuring receptor binding – Its uses.pptxTechniques for measuring receptor binding – Its uses.pptx
Techniques for measuring receptor binding – Its uses.pptx
 
Infrared spectroscopy
Infrared spectroscopyInfrared spectroscopy
Infrared spectroscopy
 
Analytical techniques in pharmaceutical
Analytical techniques in pharmaceuticalAnalytical techniques in pharmaceutical
Analytical techniques in pharmaceutical
 
FT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharm
FT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharmFT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharm
FT-IR spectroscopy Instrumentation and Application, By- Anubhav singh, M.pharm
 
Nephelometry and Turbidimetry
Nephelometry and TurbidimetryNephelometry and Turbidimetry
Nephelometry and Turbidimetry
 
Application of ir
Application of irApplication of ir
Application of ir
 
Advanced chromatographic techniques application Aquatic environmental studies...
Advanced chromatographic techniques application Aquatic environmental studies...Advanced chromatographic techniques application Aquatic environmental studies...
Advanced chromatographic techniques application Aquatic environmental studies...
 
INTRODUCTION TO SPECTROCOPY
INTRODUCTION TO SPECTROCOPYINTRODUCTION TO SPECTROCOPY
INTRODUCTION TO SPECTROCOPY
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009
 

Plus de Patel Parth

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copyPatel Parth
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013Patel Parth
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us euPatel Parth
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oralPatel Parth
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Patel Parth
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarPatel Parth
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)Patel Parth
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Patel Parth
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical techniquePatel Parth
 
23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage formsPatel Parth
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotechPatel Parth
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002Patel Parth
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014Patel Parth
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007Patel Parth
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001Patel Parth
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005Patel Parth
 
Pyrogen 112070804004
Pyrogen  112070804004Pyrogen  112070804004
Pyrogen 112070804004Patel Parth
 

Plus de Patel Parth (20)

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copy
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us eu
 
Anda ppt
Anda pptAnda ppt
Anda ppt
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oral
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminar
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018
 
Agencies dhwani
Agencies dhwaniAgencies dhwani
Agencies dhwani
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical technique
 
23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002
 
Chi square test
Chi square testChi square test
Chi square test
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005
 
Pyrogen 112070804004
Pyrogen  112070804004Pyrogen  112070804004
Pyrogen 112070804004
 

4016 solid state analysis

  • 1. Solid state analysis and degradation profile DEPARTMENT OF QUALITY ASSURANCE 1
  • 2. INTRODUCTION • The normal route of administration for most pharmaceutically active agents is through the use of solid dosage forms, and these units are ordinarily produced by the formulation and processing of powdered solids. • The priority of regulatory bodies has always focused on concerns of safety and efficacy, which led to emphasis on aspects of chemical purity.
  • 3. • This situation has changed drastically over the past decade, with an ever-increasing degree of attention being given to the physical properties of the solids that compromise a dosage form. • solid-state reactions can affect the stability of a drug entity, so physical aspects of a formulation can not be ignored.
  • 4. • sufficient physical information is necessary for formulator to overcome problems. • For a well-understood system, it is theoretically possible to design an automated or semi automated manufacturing scheme for which the processing variables are appropriately controlled and the possibility of batch failure is, hence, minimized. • It is presently recognized that to avoid problems during drug development, the physical characterization of bulk drugs, excipients, and blends of them should become part of the normal process.
  • 5. • Study of polymorphs and solvatomorphs is very important. • The nature of the crystal structure adopted by a given compound upon crystallization exerts a profound effect on the solid-state properties of that system, and that these variations can translate into significant differences in properties is of pharmaceutical importance. • It is now accepted that an evaluation of the polymorphism available to a drug substance must be thoroughly investigated early during the stages of development.
  • 6. • The results of these studies must be included in the chemistry, manufacturing, and control section of a new drug application, and such information is required to demonstrate control over the manufacturing process. • Therefore a systematic approach to the physical characterization of pharmaceutical solids has been outlined and serves as a useful device for the classification of the many methods of physical characterization.
  • 7. • Based on this system, physical properties are classified as being associated with • The molecular level (those associated with individual molecules), • The particulate level (those pertaining to individual solid particles), • The bulk level (those associated with an assembly of particulate species).
  • 8. • I. PROPERTIES ASSOCIATED WITH THE MOLECULAR LEVEL • A. Ultraviolet/Visible Diffuse Reflectance Spectroscopy • B. Vibrational Spectroscopy • C. Nuclear Magnetic Resonance Spectrometry • II. PROPERTIES ASSOCIATED WITH THE PARTICULATE LEVEL • A. Microscopy • B. X-Ray Diffraction • C. Thermal Methods of Analysis • III. PROPERTIES ASSOCIATED WITH THE BULK LEVEL • A. Particle Size Distribution • B. Micromeritics • C. Powder Characterization.
  • 9. PROPERTIES ASSOCIATED WITH THE MOLECULAR LEVEL • A. Ultraviolet/Visible Diffuse Reflectance Spectroscopy • B. Vibrational Spectroscopy • C. Nuclear Magnetic Resonance Spectrometry
  • 10. A. Ultraviolet/Visible Diffuse Reflectance Spectroscopy • Most solids are too opaque to permit the conventional use of ultraviolet/visible (UV/VIS) electronic spectroscopy. • As a result, such work must be performed using diffuse reflection techniques. • Ultraviolet/Visible Diffuse Reflectance Spectroscopy is applied to • -- study the reaction pathways of various solid-state reactions. • --The fields of colour measurement and colour matching, areas that can be of considerable importance when applied to the coloring agents used in formulations.
  • 11. • It is very useful tool for the study of interactions among various formulation components, and the technique has been successfully used in the characterization of many solid-state reactions. • Investigations conducted under appropriately designed stress conditions have been useful in the study of drug-excipient interactions, drug degradation pathways, and alterations in bioavailability .
  • 12. • EX: diffuse reflectance spectroscopy is used to study the adsorption of spiropyrans onto pharmaceutically relevant solids. • The particular adsorbents studied were interesting in that the spectral characteristics of the binary system depended strongly on the amount of material bound. • At low concentrations, the pyran sorbent exhibited its main absorption band around 550 nm. • As adsorption increased, the 550-nm band was still observed, but a much more intense absorption band at 470 nm became prominent.
  • 13. • This secondary effect was attributed to the presence of pyran–pyran interactions, which became more important as the concentration of sorbent increased.
  • 14. B. Vibrational Spectroscopy • Mid-infrared electromagnetic radiation is 400– 4000 cm−1 utilized for analysis based on fundamental vibrational modes of a chemical compound. • Fourier-transform infrared spectroscopy (FTIR) is now the method of choice. • Vibrational transitions also can be observed using Raman spectroscopy. • Overtones and combination bands of vibrational modes are observed in the near-infrared region of the spectrum (4000–13,350 cm−1).
  • 15. • This all techniques are utilized for the physical characterization of pharmaceutical solids. • When the structural characteristics of a solid affects the pattern of vibrational motion for a given molecule, these alterations can be used as a means to study the solid-state chemistry of the system. • FTIR spectra often are used to evaluate : --the type of polymorphism that exists in a drug substance and --can be very useful to study the water contained within hydrate species.
  • 16. • Solid-state IR absorption spectra often are obtained on powdered solids through the combined use of FTIR and diffuse reflectance detection, and interpreted through conventional group frequency compilations. • For example, glisentide has been obtained in a number of polymorphic and solvatomorphic forms, with the anhydrous forms I and II exhibiting large differences in infrared spectra. • The IR spectra of forms I and II are shown in Figure 1.
  • 17. FIGURE 1 Infrared absorption spectra of glisentide: upper trace, form I; lower trace, form II.
  • 18. • It can be noted that two bands assigned to the urea carbonyl group are found at 1635 and 1545 cm−1 in form I and at 1620 and 1545 cm−1 in form II. In addition, the shoulder that is present in both forms is more intense in the spectrum of form II. • The S O stretching band is observed at 1157 cm−1 in the spectrum of form I, but for form II it shifts to 1165 cm−1. • The aromatic carbonyl group at 1720 cm−1 is present in both spectra, but is broadened in the case of form II.
  • 19. • Another technique of vibrational spectroscopy that is ideally suited for characterization of solids is Raman spectroscopy. In this methodology, the sample is irradiated with monochromatic laser radiation, and the inelastic scattering of the source energy is used to obtain a vibrational spectrum of the analyte.
  • 20. • The Raman spectrum generally resembles the spectrum obtained using the FTIR method. • Differences in peak intensity are often observed. (Owing to the fundamentally different selection rules associated with the phenomenon) • In general, symmetric vibrations and non- polar groups yield the most intense Raman scattering bands. whereas antisymmetric vibrations and polar groups yield the most intense infrared absorption bands.
  • 21. EX. • Raman spectroscopy was used to study the effect of pressure and temperature on the phase composition of fluoranil crystals. • Figure 2 shows the Raman spectra obtained at a series of increasing pressures, where the changes in band frequency indicate the existence of pressure-induced phase transitions.
  • 22. FIGURE 2 Raman spectra obtained at 300 K for crystalline fluoranil at pressures of (a) 1 atm, (b) 0.5 GPa, (c) 1.4 GPa, and (d) 2.4 GPa.
  • 23. • It was deduced from sharp discontinuities in the Raman spectra that a phase transition took place at a temperature of around 180 K if the pressure was 1 atm. • This transition shifted to 300 K if the pressure was increased to 0.8 GPa.
  • 24. • Near-IR spectra consist of overtone transitions of fundamental vibrational modes and are not, therefore, generally useful for identity purposes without the use of multicomponent analysis. • But it is utilized in solid state analysis of the compounds that contain unique hydrogen atoms. • For example, studies of water in solids can be easily performed through systematic characterization of the characteristic OH band, usually observed around 5170 cm−1. • The determination of hydrate species in an anhydrous matrix can be performed easily using near-IR analysis.
  • 25. • The near-IR technique has been used very successfully for moisture determination, whole tablet assay, and blending validation. • It is possible to use the overtone and combination bands of water to develop near- IR methods that have accuracy equivalent to that obtained using Karl–Fischer titration.
  • 26. C. Nuclear Magnetic Resonance Spectrometry • The ultimate molecular level characterization of a pharmaceutical material is performed on the level of individual chemical environments of each atom in the compound, and this information is best obtained by NMR spectroscopy. • Advances in instrumentation and computer pulse sequences currently allow these studies to
  • 27. • Solid-state NMR spectra is used to deduce nature of polymorphic variations, especially when polymorphism is conformational in nature. e.g. during development of Fosinopril sodium, a crystal structure was solved for most stable phase, but no such structure could be obtained for its metastable phase.
  • 28. • NMR data suggest that additional conformational between the two polymorphs were associated with cis-trans isomerization along the peptide bond, which intern results in the presence of non equivalent molecules existing in the unit cell.
  • 29. Why solid NMR spectrum is so different from liquid NMR? • There are 3 major factors: 1) dipolar broadening :  The presence of a group of spins around a given spin may result in a number of interactions. The most important interaction between the spin and its surrounding spins is the dipolar interaction. It could be homonuclear or heteronuclear dipolar coupling. It is the dominant broadening factor in organic solids.
  • 30. For the case of two spins, I and S , the approximate dipolar Hamiltonian can be written as:  Hd = ½ ϒHϒCh2 (1-3cos2θ)(3IzSz-I×S) rHC in liquid, all possible values of θ exist due to reorientational motion. The average value of cos2 θ is 1/3, 1[1] and the dipolar coupling averages to zero. In a crystal powder or amorphous solid, all orientations occur, cos2 θ does not average to zero, there is a non
  • 31. • -zero dipolar coupling, produce a broad line. This broadening may be of the order of 20 kHz. 2) Chemical Shift Anisotropy (CSA) • This broadening factor arises from asymmetry in the electron density surrounding a given nucleus. In liquids an average chemical shift is observed due to averaging over all orientations on a timescale short in comparison with the NMR measurement time.
  • 32. • In solid, a complex line shape result from a sum of all possible chemical shifts. • The chemical shift anisotropy is again related to the term (3cos2θ-1). This term could be zero when the angle q is equal to 54044’. It is called magic angle. • In practical circumstances, high resolution solid state NMR spectra can be obtained using a combination of dipolar decoupling and magic angle spinning (MAS).
  • 33. • The dipolar decoupling is similar to that observed in liquid NMR. When acquiring a 13C spectrum, proton decoupling is needed to decouple the proton attached to the carbon, since all other protons dipolar coupling are averaged by molecule self orientation. • In the solid ,high power decoupling is necessary because of abundance of NMR active nuclei nearby, and could not average the interaction to zero.
  • 34. • This is one of the reasons to use MgO to dilute the organic solids sample to avoid homonuclear dipolar coupling. The effect of , MAS is to remove chemical shift anisotropy and dipolar coupling . However , in order to suppress dipolar couplings, the spinning speed should fast than the strength of coupling in Hz.
  • 35. 3) Spin-spin Relaxation and Spin Lattice Relaxation • The solids ,spin – spin relaxation time T2 is very short due to restricted motion. Under ideal conditions, the residual line width following decoupling and MAS will be determined by the magnitude of T2. the inherent line width is therefore much broad than that found in liquid state NMR, in tens of Hz is normal .
  • 36. • In solid, spin lattice relaxation is very inefficient and T1 is very long, in tens of seconds, due to the restricted motion. A long pulse delay is required to re-establish thermal equilibrium. This could be over come by using cross polarization technique. • To observe rare spins 13Cin solids, there are no significant homonuclear couplings since they are far away from each other in the sample .on the other hand, the hetronuclear coupling between the rare spins(13C) and abundant spins(1H) are dominant.
  • 37. • By using abundant spins to enhance the rare spin signals under appropriate condition is known as polarization transfer or cross-polarization. • In liquids, the polarization transfer was originally achieved by experiment INEPT. In solids , the polarization transfer could be achieved by spin lock under Hartmann- Hahn condition.
  • 38. Properties Associated With Particulate Level:- • Particulate properties are defined as those material characteristics that effectively can be determined by the analysis of a relatively small ensemble of particles. I. Microscopy i. X-Ray diffraction ii. Thermal mode of analysis
  • 39. i. Microscopy :- Estimation of the particle size distribution in a powdered sample is obtained by microscopy method . The relative crystallinity of the material readily determined by this method . The micromeritic and bulk powder property of the material is highly influenced by the evaluation of the morphology of pharmaceutical solids. There are mainly two types of microscopy ; 1) Optical microscopy 2) Electron microscopy
  • 40. Magnificent limit for Optical Microscopy for routine work is 600x,whereas electron microscopy can be performed at extraordinarily high magnification levels up to 90,000X on most units and the images contain three-dimensional information.
  • 41. B)X-Ray Diffraction • The fundamental structural information on crystalline substances obtained by the technique of X-ray diffraction. • Bragg explained the diffraction of x-rays by crystals using a model where the atoms of a crystal are regularly arranged in space and where they can be regarded as lying in parallel sheets separated by a definite and defined distance.
  • 42. • Application 1) Determination of crystal structures 2) Evaluation of polymorphism 3) Solvate Structures 4) Evaluation of degrees of crystallinity
  • 43. (c) Thermal Methods of Analysis • This analytical method is used to characterize compound purity, polymorphism, salvation, degradation and excipient compatibility • By the thermal analytical method endothermic processes (melting, boiling, sublimation, vaporization, desolvation, solid-solid phase transitions and chemical degradation) as well as exothermic
  • 44. • Processes (crystallization and oxidative decomposition) can be evaluated. • These are the techniques used to determine a property of the analyte as a function of an externally applied temperature. The property of analyte is evaluated on a continuous basis as a function of temperature. • The major advantage of this method is it is extremely useful during the conduct of preformulation studies, because carefully
  • 45. • planned studies can be used to indicate the existence of possible drug-excipient interactions in a prototype formulation.
  • 46. Differential Thermal Analysis(DTA) • This technique of thermal analysis is having an excellent qualitative advantage that is useful to deduce the temperature ranges associated with a variety of thermal events, as well as to assign the endothermic or exothermic nature of these reactions. • DTA represents an improvement to the melting point determination in that the
  • 47. • Different temperature between the sample and a reference is monitored as a function of temperature. • However, differences in temperature between the sample and reference are manifested when changes occur that require a finite heat of reaction. • When the heat capacities of the two that is sample and reference roughly equivalent the temperature of the sample and the reference will be same due to the no theremal transitions take place
  • 48. • If for the transition is positive (endothermic reaction) the temperature of the sample will lag behind that of the reference (because more heat will be absorbed by the sample than by the reference) and this event will be recorded in the thermogram as a negative-going peak. • If the H is negative (exothermic reaction) , the temperature of the sample will exceed that of the reference (because the sample itself will be a source of additional heat ) and the event will be recorded in thermogram as a positive going peak.
  • 49. Differential scanning Calorimetry (DSC) • An improvement to DTA analysis is Differential scanning Calorimeter (DSC) and has become one of the most widely used methods of thermal analysis. • DSC method involves the measurement of the heat flow required to maintain the equality in temperature between the sample and the reference when they kept at same temperature.
  • 50. • By placing separate heating elements in the sample and the reference cell, the equality can be achieved. The rate of heating by these elements is controlled and measured. • This method of measurement is termed power-compensation DSC, and it yields positive-going peaks for endothermic transitions and negative going peaks for exothermic transitions.
  • 51. Lactos monohydrate (Fig:b) • The thermal transitions can be seen in the DSC curves. The curve for anhydrous lactose (fig. a) shows an endothermic melting peak at about 235 C • The lactose monohydrate (fig. b) dehydrates around 150 C ; the resulting anthydrous lactose melts at about 220 C • The small exothermic peak at 180 C can be attributed to the recystallisation of some of the anhydrous lactose into mixed crystal the thermal effects after the melting peak of lactose are the result of melting of the mixed crystal and of decomposition of the liquefied lactose.
  • 52. Thermogravimetry (TG) • The thermally induced weight loss of a material is measured as a function of the applied temperature” is the main principle behind the thermogravimety (TG) of thermoanalytical technique. • The quantitative determination of the total volatile contents of a solid is the major use of TG analysis. The magnitude of each step can be separately evaluated, when a solid decompose by means of several discrete, sequential reactions.
  • 53. • It is most commonly used to study desolvation Processes and compound decomposition because this method is restricted to studies that involve either a mass gain or loss (usually loss). • The stability of similar compounds can be compare by TG analysis of compound decomposition. The higher the decomposition temperature of given compound, the more negative is the G vaiue and therefore the greater is the stability.
  • 54. For E.g Degradation pattern of CuSO4. 5H2O • CuSO4. 5H2O -- CuSO4. H2O (90 to150 C) • CuSO4. H2O --- CuSO4 (200 to 274 C) • CuSO4 ------CuS +SO2 ½ O2 (700 to 900 C) • 2CuO -- Cu2O + ½ O2 (1000 to 1100 C)
  • 55. PROPERTIES ASSOCIATE WITH BULK LEVEL • Bulk properties are those characteristics of a solid that can be measured only for large ensemble particles. • In latter stages of drug development the physical characteristic compatibility of drug with other formulation ingredients is in important. • Excipients show physical effects like enhancing powder compaction promoting dissolution, modifying drug release rate and improve powder flowabillty
  • 56. • This evaluation requires program for physical characterization of excipients especially w.r.t properties related to their use and functionaliy.
  • 57. Particle size Distribution • Particle size distribution of API and excipients exerts profound effect on mixing and possible segregation and hence affect bioavailability and powder flowability. • In absence of electrostatic effects, it is easy to produce homogenously mixed powders if the individual components to be mixed are of equivalent particle size.
  • 58. • All pharmaceutical dosage forms must be uniform and good content uniformity is possible only when particle size of API is carefully controlled. • Variety of methods are available for this determination • Optical microscopy (usually combined with image analysis ) • Sieve analysis • Laser light scattering of suspended particles • Electrical zone sensing
  • 59. • When proper sampling techniques are use, most absolute method used is Microscopy which becomes most efficient when combined with some form of image analysis • In automated method, microscope parameters are adjusted to optimize contrast between background and particles to be sized video image of powder is transmitted to a computer system which counts the number of pixels that make up a particle.
  • 60. • The size of each pixel is easily converted to um and data are analyzed as desired- Average particle size, Full weight distribution or Shape information, etc.
  • 61. Advantages of optical Microscopy :- • Provides direct and absolute information on the particles under study. • Sieve analysis is simplest and widely used method. • Here the particles are allowed to distribute among a series of sieves (typically wire mesh) and the amount of material retained on each sieve is determined.
  • 62. • FINES– Smaller particles that passes through sieve • COARSE particles– Larger particles that remains on sieve • MEDIUM fractions – when multiple sieves are used the intermediate sized particles that passes through one or more sieve but retained on subsequent sieve. • Facilitation method like vibration ultrasound or air suspension are used to assist the passage of particles through various
  • 63. • A proper size detemination required use of 5-6 sieves whose sizes are selected to obtain approx. equal amount of powder on each sieves and past the smallest sieve. • % material retained on each sieve. Cumulative% of sample retained and % sample passing each sieve are obtained. • Electrical zone sensing (is based on the coulter principle ) use measurement of electrical pulses caused by passage of particles through a sensing zone to get size information.
  • 64. Micromeritics :- • For powders, micromeritics is related to the nature of the surfaces that make up the solid. • Of all the properties that could be measured Surface area Porosity and Density are most revelant pharmaceutical parameters.
  • 65. • SURFACE AREA – Provides information on the available void spaces on surface of a powdered solid and Dissolution rate is also partially determined. • Most reproducible measurements of the surface area of solids are obtained by adsorbing a monolayer of inert gas onto the solid surface at reduced temperature and subsequently desorbing this gas at room temperature. The sorption isotherms are them interpreted using equations of BET method.
  • 66. • Unit- square meters of surface per gram of material • POROSITY – mercury intrusion porosimetry is the most widely used method to detemine pore size distribution of a porous Materials and void size of tablets and compacts. This method is based on capillary rise phenomena where excess pressure is required to force a nonwetting liquid into a narrow volume.
  • 67. • Mercury with contact angle of approx. 140 with glass is commonly used as an intrusion fluid it is forced into the pores of a sample using as an intrusion fluid. It is forced into the pores of a sample using an externally applied pressure where the smallest pores require highest pressure to effect filling. • DENSITY- is ratio of mass to volume 3 types of density which differ in their determination of volume occupied by the powder are normally differentiated.
  • 68. • Bulk density is obtained by measuring the volume of known mass of powder sample (that has been passed through a mesh screen ) into a suitable volume measuring apparatus like graduated cylinder. The bulk density is then obtained by dividing the mass of solid by the unsettled apparent volume. • Tapped density is obtained by measuring the volume of solid after subjecting the system to a number of controlled shocks. Into a smaller volume. So tapped density is always higher than bulk density.
  • 69. • True density is an intrinsic property of the analyte and is determined by composition of the unit cell. It is average mass per unit volume, exclusive of all voids that are not a fundamental part of the molecular packing arrangement. • It is measured by Helium pycnometry, where the volume occupied by a know mass of powder is determined by measuring the volume of gas disolaced by the powder.
  • 70. Powder Characterization • Flowability of powder is important parameter for formulators because the materials need to be moved from place to place. • E.g. For tablets compressed at high speed the efficiency of machine is suitable only it powder feed delievered at high rate. • Many pharmaceutical compounds with cohesive nature have undersirable flow properties.
  • 71. • One of the alms of granulation is to reduce this cohesiveness to produce uniform blend with more suitable physical properties. • Powder flowability is evaluated using • Angle of repose (angle formed when a cone of powder is poured onto a flat surface) • Angle of spatula ( angle formed when material is raised on a flat surface out of a bulk pile)
  • 72. • Compressibility (obtained from measurement of the bulk and tapped densities) • Cohesion (attractive forces that exist on particle surfaces )
  • 73. IMPURITIES AND DEGRADATION PROFILE • What is Impurities ??? – Impurities in pharmaceuticals are the unwanted chemicals that remain with API or develop during formulation or upon aging. – The presence of these unwanted chemicals even in small amounts may influence the efficiency and safety of the products. 73
  • 74. Source of Impurities in Formulation Impurities associated with Impurities created during formulation & API aging or related to formulation forms Organic Inorganic Residual Process Environmental Dosage Form Functional Impurities Impuritie Solvents Related Related factor related Group s related 74
  • 75. Impurities Associated with API Organic Impurities (Process / Degradation Product) Starting By products Reagents, Degradation Material Ligands, Catalyst Product e.g. e.g. 4- Diacetylated Mandelic acid in e.g. Hydroxy aminophenol Paracetamol as Esomeprazole acid in in by product in Mag. Simvastatin, Paracetamol, manufacturing Impurity D in Loratadine in of Paracetamol Amlodipine Desloratadine Besylate 75
  • 76. DEGRADATION • Solid state drug degradation occurs in a solution phase (in solvent layers associated with the solid phase ) source of solvent for such decomposition reaction may be :- • A) A melt from the drug it self or an ingredient in the formulation with low melting point • B) Residual moisture or solvent from wet granulation.
  • 77. • C) Moisture adsorbed onto excipients such as starch, lactose, or microcrystalline cellulose. • D) Adsorbed atmospheric moisture or • E) Solvate or hydrate that losses its “bound” Solvent with time or temperature fluctuation.
  • 78. Chemical decomposition of drugs in solid state can be divided into 4 categories :- (1) solvolysis /Hydrolysis :- • It is most important reaction for solid state drug degrade on occuring mainly in compounds containing acy group involving decomposition of drug by reaction with solvent like Hydrolysis (with water as solvent) or other like decarboxylation, etc.
  • 79. • Solvent acts as nucleophile attacking the electropositive center in drug molecules. E.g. NSAIDs, Barbiturates Vitamins, etc.
  • 80. Protection against Hydrolysis • Hydrolysis occurs in presence of moisture H+ or OH so protection steps from this reaction mainly involves their elimination from the drug system like- • (a) Buffer :- it stabilizes the drug. Ph of solution is adjusted to give maximum drug stability and therapeutic activity. • (b) Complexation :- Hydrolysis of Benzocaine in aq solution is inhibited by addition of caffeine which forms a complex with it
  • 81. • (c ) suppression of solubility :- as drug solubility decreases. The conc of drug in solution phase also decreases so rate of hydrolysis is reduced. • (d) Removal of water :- as water is responsible for hydrolysis its contacts with the drug is avoided in the preparation by • Storing drug in dry form E.g. streptomycin dry powder injection. • Using water immiscible vehicle for drug dispersion E.g. Aspirin in silicone fluid.
  • 82. Oxidation • It involves interaction of a chemical with oxygen mostly in a solvent although there are examples where oxygen may be able to oxidize drug in absence of a solvent. • Oxidation means removal of electrons, electropositive atom or radical or addition of oxygen or removal of hydrogen • 2 main types are :-
  • 83. • Proceed slowly under influence of atmospherice oxygen • Reversible loss of electrons without addition of Oxygen E.g. Adrenaline Riboflavin • In Pharmaceutical dosage forms, oxidation is usually AUTOOXIDATION (mediated by reaction with atmospheric oxygen under ambient condition ) E.g. Autooxidation of unsaturated fatty acids in fats and oils.
  • 84. • E.g. Promethazine, Vitamin A Riboflavin Morphine, etc. • System can be protected against oxidation by following ways :- • (a) Antioxidants : - they or prevent the oxidation process. E.g. Tocopehrol, Butylated Hydroxyl Anisole (BHA) , Butylated Hydroxyl Toluene (BHT), propyl gallate, etc, • (b) Adjustment of Ph :- Potential (E) is influenced by PH of system . Decrease in Ph caused rise in E and hence increases resistance to oxidation.
  • 85. • (c ) Micellar Solubilization :- Surfactans such as polysorbate enhances the rate of oxidation ascorbic acid at low conc but protects above its critical micelle conc (CMC) by entrapping the drug in spherical micelle.
  • 86. Photolysis • Photolysis of drugs like phenothiazine and vitamin A need Presence of solvent but sometimes such solvent-dependant reaction may not be needed. • Light may cause substantial degradation of drug molecule by absorbing energy of particular wavelenght. • Photochemical reaction – Molecules absorbing light takes part in photolysis and photosensitization –absorbing molecules don’t participate in photolysis.
  • 87. • Photons of shorter wavelength have more energy so uv visible light can cause phctolysis. • E.g. Photodegradation of sodium Nitroprusside in aq solution • Photo toxicity caused by drug is common Problem the Primary reaction for initiating this toxicity is generation of singlent-state excited oxygen. • Prevention-store in dark or enclose it in an opaque wrapper or in light resistance containers which donot transmit more than 15 % of incident radiation between 290-
  • 88. Pyrolysis • It is thermally induced bond rupture occuring in absence of solvent. It is normally not an important mechanism except when the drug is exposed in processing to a very high temp. • E.g. P-aminosalicylic acid degradation at 70-80 c range in the absence of molsture show a significant pyrolysis.
  • 89. REFERENCES • 1) Ahuj Satinder, scypinki stephen. Handbook of modem Pharmaceutical analysis 3rd ed. Academic press • 2) Zornoza A, de No. C., Goni M.M. Martinez Oharriz M.C., and Velaz I lnt J. pharm. 186. 199. 1999. • 3) http:/www.emory.edu/NMR/Hall/solid/index .htm • 4) http:/www.bionmr- c1.unl.edu/921/Lectures/chapter11-solid-